Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M I Lucena

Showing results (1-10 of 75) with videos related to

Pageof 8
Sort By:
Methods and Findings in Experimental and Clinical Pharmacology|December 22, 1999
Working group on hepatotoxicity studiesM I Lucena
Medicina Clinica|April 25, 1992
[Right to reply to the reviewer]R Andrade, M I Lucena
The American Journal of Medicine|November 1, 1990
Extrahepatic cholestasis as a distinct factor predisposing to gentamicin nephrotoxicityM I Lucena, R J Andrade
The American Journal of Gastroenterology|April 1, 1995
Interferon treatment of cirrhotic patients with chronic hepatitis CR J Andrade, M I Lucena
Medicina Clinica|October 14, 1995
[Aminoglycoside nephrotoxicity and obstructive jaundice]M I Lucena, R J Andrade
Revista Espanola De Enfermedades Digestivas|April 21, 2005
Increasing the detection of hepatotoxic response in clinical practice: a quality commitmentM I Lucena, R J Andrade
Revista Espanola De Enfermedades Digestivas|August 8, 2001
Is drug-induced hepatotoxicity unavoidable?R J Andrade, M I Lucena
Gastroenterologia Y Hepatologia|January 12, 1999
[Clinical hepatology and pharmacoepidemiology: a pending multidisciplinary approach]R J Andrade, M I Lucena, G Tognoni
Actas Espanolas De Psiquiatria|April 3, 2007
[Olanzapine-associated neuroleptic malignant syndrome. A case report and favorable response to risperidone]E López-Torres, I Cobo, M I Lucena
The Annals of Pharmacotherapy|January 7, 1999
Hepatic injury associated with losartanR J Andrade, M I Lucena, F Santalla
Pageof 8

Showing results (1-10 of 75) with videos related to

Sort By:
Pageof 8
Methods and Findings in Experimental and Clinical Pharmacology|December 22, 1999
Working group on hepatotoxicity studiesM I Lucena
Medicina Clinica|April 25, 1992
[Right to reply to the reviewer]R Andrade, M I Lucena
The American Journal of Medicine|November 1, 1990
Extrahepatic cholestasis as a distinct factor predisposing to gentamicin nephrotoxicityM I Lucena, R J Andrade
The American Journal of Gastroenterology|April 1, 1995
Interferon treatment of cirrhotic patients with chronic hepatitis CR J Andrade, M I Lucena
Medicina Clinica|October 14, 1995
[Aminoglycoside nephrotoxicity and obstructive jaundice]M I Lucena, R J Andrade
Revista Espanola De Enfermedades Digestivas|April 21, 2005
Increasing the detection of hepatotoxic response in clinical practice: a quality commitmentM I Lucena, R J Andrade
Revista Espanola De Enfermedades Digestivas|August 8, 2001
Is drug-induced hepatotoxicity unavoidable?R J Andrade, M I Lucena
Gastroenterologia Y Hepatologia|January 12, 1999
[Clinical hepatology and pharmacoepidemiology: a pending multidisciplinary approach]R J Andrade, M I Lucena, G Tognoni
Actas Espanolas De Psiquiatria|April 3, 2007
[Olanzapine-associated neuroleptic malignant syndrome. A case report and favorable response to risperidone]E López-Torres, I Cobo, M I Lucena
The Annals of Pharmacotherapy|January 7, 1999
Hepatic injury associated with losartanR J Andrade, M I Lucena, F Santalla
Pageof 8